124 related articles for article (PubMed ID: 25107406)
1. Interplay between amino acid residues at positions 192 and 115 in modulating hydrolytic activities of human paraoxonase 1.
Bajaj P; Aggarwal G; Tripathy RK; Pande AH
Biochimie; 2014 Oct; 105():202-10. PubMed ID: 25107406
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human paraoxonase 1 variants suggest that His residues at 115 and 134 positions are not always needed for the lactonase/arylesterase activities of the enzyme.
Bajaj P; Tripathy RK; Aggarwal G; Pande AH
Protein Sci; 2013 Dec; 22(12):1799-807. PubMed ID: 24123308
[TBL] [Abstract][Full Text] [Related]
3. Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192.
Aggarwal G; Prajapati R; Tripathy RK; Bajaj P; Iyengar AR; Sangamwar AT; Pande AH
PLoS One; 2016; 11(2):e0147999. PubMed ID: 26829396
[TBL] [Abstract][Full Text] [Related]
4. Towards Understanding the Catalytic Mechanism of Human Paraoxonase 1: Experimental and In Silico Mutagenesis Studies.
Tripathy RK; Aggarwal G; Bajaj P; Kathuria D; Bharatam PV; Pande AH
Appl Biochem Biotechnol; 2017 Aug; 182(4):1642-1662. PubMed ID: 28161867
[TBL] [Abstract][Full Text] [Related]
5. Analysis of active-site amino-acid residues of human serum paraoxonase using competitive substrates.
Yeung DT; Lenz DE; Cerasoli DM
FEBS J; 2005 May; 272(9):2225-30. PubMed ID: 15853807
[TBL] [Abstract][Full Text] [Related]
6. Identification of residues essential for human paraoxonase (PON1) arylesterase/organophosphatase activities.
Josse D; Xie W; Renault F; Rochu D; Schopfer LM; Masson P; Lockridge O
Biochemistry; 1999 Mar; 38(9):2816-25. PubMed ID: 10052953
[TBL] [Abstract][Full Text] [Related]
7. Evidence that several conserved histidine residues are required for hydrolytic activity of human paraoxonase/arylesterase.
Doorn JA; Sorenson RC; Billecke SS; Hsu C; La Du BN
Chem Biol Interact; 1999 May; 119-120():235-41. PubMed ID: 10421457
[TBL] [Abstract][Full Text] [Related]
8. Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli.
Bajaj P; Tripathy RK; Aggarwal G; Pande AH
Protein Expr Purif; 2015 Nov; 115():95-101. PubMed ID: 26003526
[TBL] [Abstract][Full Text] [Related]
9. Catalytic versatility and backups in enzyme active sites: the case of serum paraoxonase 1.
Ben-David M; Elias M; Filippi JJ; Duñach E; Silman I; Sussman JL; Tawfik DS
J Mol Biol; 2012 May; 418(3-4):181-96. PubMed ID: 22387469
[TBL] [Abstract][Full Text] [Related]
10. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.
Bryk B; BenMoyal-Segal L; Podoly E; Livnah O; Eisenkraft A; Luria S; Cohen A; Yehezkelli Y; Hourvitz A; Soreq H
J Neurochem; 2005 Mar; 92(5):1216-27. PubMed ID: 15715671
[TBL] [Abstract][Full Text] [Related]
11. Human paraoxonase 1 as a pharmacologic agent: limitations and perspectives.
ScientificWorldJournal; ; . PubMed ID: 25386619
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
